N-(4-(5-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1H-benzoimidazol-1-yl)phenyl)acetamide

ID: ALA5196221

PubChem CID: 163322395

Max Phase: Preclinical

Molecular Formula: C28H30N4O2

Molecular Weight: 454.57

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1ccc(-n2cnc3cc(-c4ccc(OCCN5CCCCC5)cc4)ccc32)cc1

Standard InChI:  InChI=1S/C28H30N4O2/c1-21(33)30-24-8-10-25(11-9-24)32-20-29-27-19-23(7-14-28(27)32)22-5-12-26(13-6-22)34-18-17-31-15-3-2-4-16-31/h5-14,19-20H,2-4,15-18H2,1H3,(H,30,33)

Standard InChI Key:  GAXVYKWKQSGVIF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -4.0665   -2.9643    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7864   -3.3673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4980   -2.9495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4980   -2.1287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7769   -1.7214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0665   -2.1392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3586   -3.3799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6448   -2.9747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9370   -3.3903    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2232   -2.9850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2232   -2.1643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5038   -1.7559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2083   -2.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2083   -2.9977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5109   -3.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9203   -1.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6328   -2.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3453   -1.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3453   -0.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6328   -0.5299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9203   -0.9387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1315   -0.6821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6174   -1.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1315   -2.0196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3851    0.0986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8367    0.7093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0869    1.4911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8938    1.6639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4504    1.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1919    0.2713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1439    2.4457    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9461    2.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1961    3.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4980    2.0123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  1  7  1  0
  8  7  1  0
  8  9  1  0
  9 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
 13 14  1  0
 10 15  1  0
 15 14  2  0
 13 16  1  0
 17 16  2  0
 18 17  1  0
 18 19  2  0
 19 20  1  0
 16 21  1  0
 21 20  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 18 24  1  0
 22 25  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 28 29  1  0
 25 30  1  0
 30 29  2  0
 28 31  1  0
 32 31  1  0
 32 33  1  0
 32 34  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5196221

    ---

Associated Targets(Human)

ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GDM-1 (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT4 Tclin Vascular endothelial growth factor receptor 3 (3216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGF1R Tclin Insulin-like growth factor I receptor (8605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRA Tclin Platelet-derived growth factor receptor alpha (5682 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKD2 Tchem Serine/threonine-protein kinase D2 (2847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK2 Tclin Neurotrophic tyrosine kinase receptor type 2 (3279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK3 Tclin NT-3 growth factor receptor (2338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BNL (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
H9c2 (3506 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.57Molecular Weight (Monoisotopic): 454.2369AlogP: 5.52#Rotatable Bonds: 7
Polar Surface Area: 59.39Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.83CX LogP: 4.74CX LogD: 3.29
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.40Np Likeness Score: -1.48

References

1. Dokla EME, Abdel-Aziz AK, Milik SN, McPhillie MJ, Minucci S, Abouzid KAM..  (2022)  Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia.,  56  [PMID:35033885] [10.1016/j.bmc.2021.116596]

Source